Literature DB >> 16822355

State of the ketogenic diet(s) in epilepsy.

Jennifer Huffman, Eric H Kossoff.   

Abstract

Fasting has been recognized as a treatment for seizures since ancient times. The ketogenic diet is a low-carbohydrate, adequate-protein, high-fat diet that biochemically mimics the fasting state and has been used to successfully treat seizures for 85 years. The diet has enjoyed a resurgence in popularity over the past decade and is gaining acceptance and use worldwide. Many studies over the past several years have explored possible mechanisms of action for the ketogenic diet. This review addresses these studies, as well as recent research regarding possible indications for the diet, variations in its initiation, side effect profiles, and the recent use of modified formulations to improve tolerability.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16822355     DOI: 10.1007/s11910-006-0027-6

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  56 in total

1.  Risk factors for urolithiasis in children on the ketogenic diet.

Authors:  S L Furth; J C Casey; P L Pyzik; A M Neu; S G Docimo; E P Vining; J M Freeman; B A Fivush
Journal:  Pediatr Nephrol       Date:  2000-11       Impact factor: 3.714

2.  Dietary approaches to epilepsy treatment: old and new options on the menu.

Authors:  Carl E Stafstrom
Journal:  Epilepsy Curr       Date:  2004 Nov-Dec       Impact factor: 7.500

3.  Fasting versus gradual initiation of the ketogenic diet: a prospective, randomized clinical trial of efficacy.

Authors:  A G Christina Bergqvist; Joan I Schall; Paul R Gallagher; Avital Cnaan; Virginia A Stallings
Journal:  Epilepsia       Date:  2005-11       Impact factor: 5.864

4.  Efficacy of the ketogenic diet for infantile spasms.

Authors:  Eric H Kossoff; Paula L Pyzik; Jane R McGrogan; Eileen P G Vining; John M Freeman
Journal:  Pediatrics       Date:  2002-05       Impact factor: 7.124

5.  Worldwide use of the ketogenic diet.

Authors:  Eric H Kossoff; Jane R McGrogan
Journal:  Epilepsia       Date:  2005-02       Impact factor: 5.864

6.  Long-term use of the ketogenic diet in the treatment of epilepsy.

Authors:  Darcy K Groesbeck; Renee M Bluml; Eric H Kossoff
Journal:  Dev Med Child Neurol       Date:  2006-12       Impact factor: 5.449

7.  Kidney stones, carbonic anhydrase inhibitors, and the ketogenic diet.

Authors:  Eric H Kossoff; Paula L Pyzik; Susan L Furth; Heather D Hladky; John M Freeman; Eileen P G Vining
Journal:  Epilepsia       Date:  2002-10       Impact factor: 5.864

8.  Acetoacetate protects hippocampal neurons against glutamate-mediated neuronal damage during glycolysis inhibition.

Authors:  L Massieu; M L Haces; T Montiel; K Hernández-Fonseca
Journal:  Neuroscience       Date:  2003       Impact factor: 3.590

9.  Effects of the ketogenic diet in the glucose transporter 1 deficiency syndrome.

Authors:  Jörg Klepper; Sonja Diefenbach; Alfried Kohlschütter; Thomas Voit
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2004-03       Impact factor: 4.006

10.  The ketogenic diet increases mitochondrial uncoupling protein levels and activity.

Authors:  Patrick G Sullivan; Nancy A Rippy; Kristina Dorenbos; Rachele C Concepcion; Aakash K Agarwal; Jong M Rho
Journal:  Ann Neurol       Date:  2004-04       Impact factor: 10.422

View more
  12 in total

1.  Ketosis Ameliorates Renal Cyst Growth in Polycystic Kidney Disease.

Authors:  Jacob A Torres; Samantha L Kruger; Caroline Broderick; Tselmeg Amarlkhagva; Shagun Agrawal; John R Dodam; Michal Mrug; Leslie A Lyons; Thomas Weimbs
Journal:  Cell Metab       Date:  2019-10-17       Impact factor: 27.287

Review 2.  Ketogenic diets in patients with inherited metabolic disorders.

Authors:  S Scholl-Bürgi; A Höller; K Pichler; M Michel; E Haberlandt; D Karall
Journal:  J Inherit Metab Dis       Date:  2015-06-25       Impact factor: 4.982

3.  The ketogenic diet for medically and surgically refractory status epilepticus in the neurocritical care unit.

Authors:  Mackenzie C Cervenka; Adam L Hartman; Arun Venkatesan; Romergryko G Geocadin; Eric H Kossoff
Journal:  Neurocrit Care       Date:  2011-12       Impact factor: 3.210

4.  Ketogenic dietary interventions in autosomal dominant polycystic kidney disease-a retrospective case series study: first insights into feasibility, safety and effects.

Authors:  Sebastian Strubl; Simon Oehm; Jacob A Torres; Franziska Grundmann; Jazmine Haratani; Morgan Decker; Sabrina Vuong; Amrit Kaur Bhandal; Nils Methot; Rhianna Haynie-Cion; Franziska Meyer; Florian Siedek; Uwe Korst; Roman-Ulrich Müller; Thomas Weimbs
Journal:  Clin Kidney J       Date:  2021-09-13

5.  The ketogenic diet suppresses the cathepsin E expression induced by kainic acid in the rat brain.

Authors:  Hyun Jeong Jeong; Hojeong Kim; Yoon-Kyoung Kim; Sang-Kyu Park; Dong-Won Kang; Dojun Yoon
Journal:  Yonsei Med J       Date:  2010-09       Impact factor: 2.759

Review 6.  The Molecular Link from Diet to Cancer Cell Metabolism.

Authors:  Shree Bose; Annamarie E Allen; Jason W Locasale
Journal:  Mol Cell       Date:  2020-06-05       Impact factor: 19.328

7.  Inhibition of Neuroblastoma Tumor Growth by Ketogenic Diet and/or Calorie Restriction in a CD1-Nu Mouse Model.

Authors:  Raphael Johannes Morscher; Sepideh Aminzadeh-Gohari; René Gunther Feichtinger; Johannes Adalbert Mayr; Roland Lang; Daniel Neureiter; Wolfgang Sperl; Barbara Kofler
Journal:  PLoS One       Date:  2015-06-08       Impact factor: 3.240

Review 8.  Beyond weight loss: a review of the therapeutic uses of very-low-carbohydrate (ketogenic) diets.

Authors:  A Paoli; A Rubini; J S Volek; K A Grimaldi
Journal:  Eur J Clin Nutr       Date:  2013-06-26       Impact factor: 4.016

9.  Effects of ketogenic diet on the clinical and electroencephalographic features of children with drug therapy-resistant epilepsy.

Authors:  Baomin Li; Lili Tong; Guijuan Jia; Ruopeng Sun
Journal:  Exp Ther Med       Date:  2012-11-22       Impact factor: 2.447

10.  Combination of metronomic cyclophosphamide and dietary intervention inhibits neuroblastoma growth in a CD1-nu mouse model.

Authors:  Raphael Johannes Morscher; Sepideh Aminzadeh-Gohari; Cornelia Hauser-Kronberger; René Günther Feichtinger; Wolfgang Sperl; Barbara Kofler
Journal:  Oncotarget       Date:  2016-03-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.